Co-expression linked with poor prognostic markers in prostate cancer, maintaining tumor-promoting epigenetic landscapes in WPMY-1, DU145, PC-3, PC-3-shCtrl/shDNMT1#1, and WPMY-1-Vector/DNMT1/TRAF6/(DNMT1+TRAF6) cells. Here, TRAF6 is linked to prostate carcinoma.